NTC Srl, an R&D focused pharmaceutical company headquartered in Italy, has granted exclusive license and distribution rights to one of its research and development products, a fixed combination in eye drops, in Israel to Taro Pharmaceutical Industries (”Taro”), a research-based international pharmaceutical company.

The  Covid-19 situation has been evolving: the responsibility of everyone in implementing some essential measures, such as social distancing, personal hygiene and the use of protective equipment is fundamental to prevent Covid-19’s outbreak and approach safely our future social life.

Milan, April 21, 2020 – NTC Srl, an R&D focused pharmaceutical company headquartered in Italy, has granted license and distribution rights on one of its research and development products, a fixed combination in eye drops, in Mexico to Laboratorios Grin S.A. de C.V, a wholly owned affiliate of Lupin, focused on developing, manufacturing and distributing world-class medicines and a leader in the Ophthalmology segment.